Origins
When was BPC-157 created?
BPC-157 is a fifteen-residue fragment taken from a protein found in human gastric juice, first published by a group in Zagreb in the 1990s.
The short answer
| Date | The 1990s |
| Who | Predrag Sikirić and colleagues |
| Where | University of Zagreb, Croatia |
| Origin | Derived from a larger natural molecule, then made synthetically. |
Where it came from
The Zagreb group had been working on a protein they isolated from gastric juice and called body protection compound. BPC-157 is a partial sequence of it — the fragment they identified as carrying the activity they were interested in, synthesised rather than extracted.
Almost the entire published literature on BPC-157 comes from that group and its collaborators. This is unusual, and it is the single most important thing to know about the compound’s paper trail: a large number of publications is not the same as independent replication, and for BPC-157 the distinction matters more than for most compounds in this range.
The 1990s is the right answer rather than a specific year. The earliest papers appear across the first half of the decade and there is no single founding publication that the rest cite as the origin.
Why it is called that
BPC is body protection compound, the name of the parent protein. 157 identifies the fragment. Neither part is a claim about anything.
Where it stands now
BPC-157 has not been approved as a medicine in any country. It has no international nonproprietary name, and it is on the World Anti-Doping Agency’s prohibited list.
What this page does not say
Nothing above is a statement about what BPC-157 does in a body, and none of it is guidance on use. A compound’s history is a record of laboratories and dates; it is not evidence for anything, and the fact that a programme was looking for something is not a finding that it was found.
More on BPC-157
What is BPC-157? · The full timeline · BPC-157 — sizes and prices
